Myosin-XIX inhibitors represent a specialized category of chemical agents designed to modulate the activity of Myosin-XIX, a class of unconventional myosin proteins. Myosin proteins are molecular motors that interact with actin filaments to facilitate intracellular transport, cellular movement, and other critical cytoskeletal dynamics. Myosin-XIX, in particular, is distinguished by its unique motor domain and its ability to navigate actin networks in ways that differ from conventional myosins. The regulation of Myosin-XIX activity is critical for understanding cellular processes such as organelle positioning, membrane trafficking, and mechanical force generation. Inhibitors of Myosin-XIX typically target the motor domain or the associated regulatory regions, preventing the hydrolysis of ATP that powers the myosin motor. By modulating ATPase activity or disrupting actin binding, these inhibitors can prevent Myosin-XIX from executing its mechanical functions, ultimately impacting the dynamics of actin filaments and cytoskeletal integrity.
Chemically, Myosin-XIX inhibitors are diverse and can be classified based on their binding mechanisms or molecular interactions with the myosin protein. Some inhibitors may function by occupying ATP binding pockets, thereby preventing ATP hydrolysis, while others may alter the myosin-actin interaction by binding to allosteric sites on the myosin molecule. These inhibitors often exhibit high specificity for Myosin-XIX over other myosin isoforms, which is a critical factor for studying the precise role of Myosin-XIX in various cellular contexts. In research settings, the application of these inhibitors can help scientists dissect the exact functions of Myosin-XIX in complex cellular pathways, including its role in cytoskeletal organization, cell polarity, and intracellular cargo transport. Studying the chemical interactions and inhibitory mechanisms provides valuable insights into the biochemical principles that govern motor protein regulation and the broader landscape of molecular motors in cell biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 inhibitor that can destabilize client proteins, potentially affecting KRTAP9-3 stability. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Compound known to disrupt cytoskeletal proteins, which could affect KRTAP9-3's interaction with keratins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor that can reduce overall protein levels, potentially reducing KRTAP9-3 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can increase protein levels, potentially affecting KRTAP9-3 turnover. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter gene expression, potentially affecting KRTAP9-3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can affect gene expression, potentially influencing KRTAP9-3. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Cyclin-dependent kinase inhibitor that can disrupt cell cycle, potentially affecting KRTAP9-3 levels. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that can induce ER stress, potentially impacting KRTAP9-3 folding or stability. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Signaling molecule that can regulate gene expression, potentially affecting KRTAP9-3 levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent that can raise lysosomal pH, potentially affecting KRTAP9-3 degradation. | ||||||